Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
MPC Therapeutics
MPC Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
MPC Therapeutics
Total Funding
$1.6 M
MPC Therapeutics Summary
Company Summary
Overview
MPC Therapeutics is a company that develops drugs for mitochondria. Its therapeutic areas include mitochondrial carrier inhibitors, cancer immunotherapy, neurodegenerative diseases, metabolism modulation, etc.
Type
Private
Status
Active
Founded
2018
HQ
Geneva, CH
|
view all locations
Website
https://www.mpc-therapeutics.com/
Sectors
Healthcare
drug development
oncology
therapy
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Raphael Martinou,
CEO & Co-Founder
Linkedin
Augustin De Bettignies,
CBO
Linkedin
Jean-Claude Martinou,
CSO
Mathias Wenes,
Head of Immunotherapy
and 2 others
Locations
View all
1 location detected
Geneva, GE
HQ
Switzerland
Chem. des Aulx 14
Competitors and Similar Companies
Partner Therapeutics
Healthcare - Private
Andarix Pharmaceuticals
Healthcare - Private
OncoHost
Healthcare - Private
VelosBio
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top